HIGHTIDE-B (02511) fell 10% to HK$4.5.
It hits an intra-day low of HK$4.5, and an intra-day high of HK$4.98. The total shares traded was 256,000, with a value of HK$1.19m. The active buy/sell ratio is 34:66, with net selling turnover of HK$353,835. CITRUS SEC accounts for greatest net responsive buying turnover of HK$26,315, with volume weighted average price of HK$4.577. HSBC SEC BRO (ASIA) accounts for greatest net responsive selling turnover of HK$42,458, with volume weighted average price of HK$4.59.
Nominal | 4.500 | % Chg | -10.00% |
High | 4.980 | Low | 4.500 |
Shares Tr | 256,000 | Turnover | 1.19m |
10-D SMA | 5.080 | %H.V | 124.484 |
20-D SMA | 5.738 | VWAP | 4.630 |
50-D SMA | 8.650 | RSI14 | 28.632 |
Stock (Code) | Price (HK$) | Change (%) |
---|---|---|
HIGHTIDE-B (02511) | 4.50 | -10.00 |
HUTCHMED (00013) | 27.15 | -3.72 |
GENSCRIPT BIO (01548) | 11.60 | -4.61 |
INNOVENT BIO (01801) | 35.60 | -0.70 |
EVEREST MED-B (01952) | 22.55 | -5.25 |
LAEKNA-B (02105) | 6.95 | -12.58 |
SIRNAOMICS-B (02257) | 6.30 | -9.22 |
WUXI BIO (02269) | 13.34 | -1.77 |
AKESO (09926) | 46.60 | -2.82 |
REMEGEN (09995) | 27.80 | -4.79 |
全新節目《說說心理話》青少年不可以戀愛!?真實個案講述驚心動魄經歷► 即睇